Vistisen D - Search Results

1

Effects of 3 months of 10-h per-day time-restricted eating and 3 months of follow-up on bodyweight and cardiometabolic health in Danish individuals at high risk of type 2 diabetes: the RESET single-centre, parallel, superiority, open-label, randomised controlled trial.

Quist JS, Pedersen HE, Jensen MM, Clemmensen KKB, Bjerre N, Ekblond TS, Uldal S, Størling J, Wewer Albrechtsen NJ, Holst JJ, Torekov SS, Nyeland ME, Vistisen D, Jørgensen ME, Panda S, Brock C, Finlayson G, Blond MB, Færch K. Quist JS, et al. Among authors: vistisen d. Lancet Healthy Longev. 2024 May;5(5):e314-e325. doi: 10.1016/S2666-7568(24)00028-X. Epub 2024 Apr 5. Lancet Healthy Longev. 2024. PMID: 38588687 Free article. Clinical Trial.

2

Heterogeneity in glycaemic control in children and adolescents with type 1 diabetes: A latent class trajectory analysis of Danish nationwide data.

Wibaek R, Ibfelt EH, Andersen GS, Hulman A, Dabelea D, Jørgensen ME, Svensson J, Vistisen D, Rønn PF. Wibaek R, et al. Among authors: vistisen d. Diabet Med. 2024 Mar;41(3):e15275. doi: 10.1111/dme.15275. Epub 2023 Dec 29. Diabet Med. 2024. PMID: 38157300

3

Christmas article: Snacking preferences at the office during the Christmas season – a secret intervention study among diabetes researchers.

Senftleber NK, Rønn PF, Backe MB, Kosjerina V, Vistisen D, Carstensen B. Senftleber NK, et al. Among authors: vistisen d. Ugeskr Laeger. 2023 Dec 11;185(50):V202312. Ugeskr Laeger. 2023. PMID: 38084618 Free article. Danish.

4

Design and methodology of the PRIMETIME 1 cohort study: PRecIsion MEdicine based on kidney TIssue Molecular interrogation in diabetic nEphropathy.

Jensen KH, Persson F, Hansen D, Bressendorff I, Møller M, Rossing P, Gravesen E, Kosjerina V, Vistisen D, Borg R. Jensen KH, et al. Among authors: vistisen d. Clin Kidney J. 2023 Jun 24;16(12):2482-2492. doi: 10.1093/ckj/sfad150. eCollection 2023 Dec. Clin Kidney J. 2023. PMID: 38046022 Free PMC article.

5

Empagliflozin is associated with lower cardiovascular risk compared with dipeptidyl peptidase-4 inhibitors in adults with and without cardiovascular disease: EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study results from Europe and Asia.

Vistisen D, Carstensen B, Elisabetta P, Lanzinger S, Tan EC, Yabe D, Kim DJ, Sheu WH, Melzer-Cohen C, Holl RW, Núñez J, Ha KH, Halvorsen S, Langslet G, Karasik A, Nyström T, Niskanen L, Guleria S, Klement R, Carrasco M, Foersch J, Shay C, Koeneman L, Hoti F, Farsani SF, Khunti K, Zaccardi F, Subramanian A, Nirantharakumar K; EMPRISE EU; East Asia Study Group. Vistisen D, et al. Cardiovasc Diabetol. 2023 Aug 31;22(1):233. doi: 10.1186/s12933-023-01963-9. Cardiovasc Diabetol. 2023. PMID: 37653496 Free PMC article.

6

Declining Incidence Rates of Distal Symmetric Polyneuropathy in People With Type 1 and Type 2 Diabetes in Denmark, With Indications of Distinct Patterns in Type 1 Diabetes.

Mizrak HI, Hansen TW, Rossing P, Curovic VR, Vistisen D, Amadid H, Hansen CS. Mizrak HI, et al. Among authors: vistisen d. Diabetes Care. 2023 Nov 1;46(11):1997-2003. doi: 10.2337/dc23-0312. Diabetes Care. 2023. PMID: 37647323

7

Glucose Monitoring Metrics in Individuals With Type 1 Diabetes Using Different Treatment Modalities: A Real-World Observational Study.

Nørgaard K, Ranjan AG, Laugesen C, Tidemand KG, Green A, Selmer C, Svensson J, Andersen HU, Vistisen D, Carstensen B. Nørgaard K, et al. Among authors: vistisen d. Diabetes Care. 2023 Nov 1;46(11):1958-1964. doi: 10.2337/dc23-1137. Diabetes Care. 2023. PMID: 37610784

8

BALDR: A Web-based platform for informed comparison and prioritization of biomarker candidates for type 2 diabetes mellitus.

Lundgaard AT, Burdet F, Siggaard T, Westergaard D, Vagiaki D, Cantwell L, Röder T, Vistisen D, Sparsø T, Giordano GN, Ibberson M, Banasik K, Brunak S. Lundgaard AT, et al. Among authors: vistisen d. PLoS Comput Biol. 2023 Aug 17;19(8):e1011403. doi: 10.1371/journal.pcbi.1011403. eCollection 2023 Aug. PLoS Comput Biol. 2023. PMID: 37590326 Free PMC article.

9

Glycaemic control, risk of hypoglycaemia and all-cause mortality in new users of second-generation basal insulin with type 2 diabetes and chronic kidney disease: a nationwide register-based cohort study.

Kosjerina V, Carstensen B, Amadid H, Vistisen D. Kosjerina V, et al. Among authors: vistisen d. Diabetologia. 2023 Oct;66(10):1908-1913. doi: 10.1007/s00125-023-05971-y. Epub 2023 Jul 28. Diabetologia. 2023. PMID: 37505281

10

Time Trends in the Incidence of Diabetic Ketoacidosis Leading to Hospital Admission Among Adults With Type 1 Diabetes: A Nationwide Danish Register Study.

Stougaard EB, Amadid H, Søndergaard E, Carstensen B, Jørgensen ME, Nørgaard K, Rossing P, Persson F, Vistisen D. Stougaard EB, et al. Among authors: vistisen d. Diabetes Care. 2023 Nov 1;46(11):1897-1902. doi: 10.2337/dc23-0475. Diabetes Care. 2023. PMID: 37432944

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

139 results

Search Page